Skip to main content
HEALIUS LIMITED logo

HEALIUS LIMITED — Investor Relations & Filings

Ticker · HLS ISIN · AU0000033359 LEI · 529900MBZK3SLWK8SJ55 ASX Human health and social work activities
Open in API
Filings indexed 2,292 across all filing types
Latest filing 2021-02-23 Regulatory Filings
Country AU Australia
Listing ASX HLS

About HEALIUS LIMITED

https://www.healius.com.au

Healius Limited is a leading healthcare service provider specializing in pathology and diagnostic imaging services. The company operates an extensive network of pathology laboratories and collection centers, providing diagnostic testing across various medical disciplines including biochemistry, hematology, and microbiology. Its diagnostic imaging division offers a comprehensive range of services such as X-rays, ultrasounds, CT scans, and MRIs through a network of community-based and hospital-integrated clinics. Healius focuses on delivering high-quality diagnostic insights to healthcare professionals and patients, leveraging advanced technology and a large-scale infrastructure to support clinical decision-making and patient care outcomes.

Recent filings

Filing Released Lang Actions
Half Yearly Report and Accounts 43 pages 2.4MB
Regulatory Filings
2021-02-23 English
Dividend/Distribution - HLS 4 pages 25.5KB
Notice of Dividend Amount Classification · 100% confidence The document is a detailed announcement regarding a dividend distribution by Healius Limited. It includes specific information such as the dividend amount, ex-date, record date, payment date, and details about franking credits. The document is focused solely on the dividend notification and does not contain comprehensive financial statements or broader financial performance data. It is not a full annual or interim report, nor is it a management discussion or earnings release. The content matches the definition of a Notice of Dividend Amount (DIV), which announces dividend amounts, payment dates, and related details for shareholders.
2021-02-23 English
Healius announces strong 1H 2021 results, outlook positive 4 pages 594.0KB
Interim / Quarterly Report Classification · 95% confidence The document is an ASX announcement dated 24 February 2021 from Healius Limited reporting strong financial results for the half-year ended 31 December 2020 (1H 2021). It contains detailed financial performance data including revenue, EBIT, NPAT, divisional results, cash flow, balance sheet metrics, and dividend information. The document discusses the company's operational performance, outlook, and strategic initiatives for the half-year period. The presence of comprehensive financial data and analysis for a six-month period indicates this is an Interim / Quarterly Report rather than a brief earnings release or announcement. The document length (11,726 characters) and detailed content confirm it is a substantive financial report. Therefore, the appropriate classification is Interim / Quarterly Report (IR). H1 2021
2021-02-23 English
Presentation of Half Year 2021 Results 34 pages 1.3MB
Regulatory Filings
2021-02-23 English
HLS 1H 2021 results analyst and investor briefing details 1
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 24 February 2021 regarding Healius Limited's 1H 2021 results and details about an analyst and investor briefing to discuss these results. It does not contain the actual financial results or detailed financial statements but rather announces the release of the results and provides webcast and teleconference details for the briefing. The document length is short (2288 characters), and it primarily serves as a notification about the event and results release rather than the results themselves. According to the 'Menu vs Meal' rule, this is an announcement about the report and briefing, not the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback for such announcements that do not contain substantive financial data.
2021-02-23 English
Appointment of Kate McKenzie as a Non-executive Director 2 pages 538.3KB
Board/Management Information Classification · 95% confidence The document is an announcement from Healius Limited regarding the appointment of a new Non-executive Director, Kate McKenzie. It includes biographical details and statements from the Chair and the appointee. There is no financial data, no mention of financial results, no regulatory filings, no voting results, no capital changes, or other report types. The content clearly relates to a change in the company's board of directors. Therefore, the document fits the category of Board/Management Information (MANG). The document length is about 5438 characters, which is sufficient for a detailed announcement but not a full report. Hence, the classification is MANG with high confidence.
2021-02-09 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.